Competitive Strategy

How CVS Health’s Performance-Based Pharmacy is Positioned to Improve Cost and Quality across the Healthcare Continuum

Blog Posts

Fuld & Company

CVS Health’s Strategy includes the creation of Performance-Based Pharmacy Network – What does this mean for healthcare? CVS Health issued […]

How Distributors Can Navigate the Fragmentation of Vaccine Administration

Blog Posts

Eight years ago, the Affordable Care Act (ACA) implemented universal vaccine coverage, requiring private group and individual health plans to […]

Walmart’s Potential Acquisition of Humana: Competitive Strategy Implications for the U.S. Healthcare Industry

Blog Posts

I loathe the pervasive, trite metaphor that compares competitive strategy to the game of chess.  However, recent reports that Walmart is in […]

Key Takeaways from the Institute of Directors Open House, 12-14 March 2018, London

Blog Posts,

Events

Fuld & Company

The Institute of Directors (IoD), founded in 1903 and awarded a Royal Charter in 1906 is an organization that supports and […]

The Undeniable Rise of Challenger Banks in the United Kingdom: What Should the Big Four Do?

Blog Posts

Fuld & Company

How to evaluate, plan and execute a competitive counter-strategy against swift new entrants, the challenger banks. To say that the […]

Chief Marketing Officer Exchange Presentation

Events

Robert Flynn, Principal, delivers breakout presentation at Chief Marketing Officer Exchange. February 11 – 13, 2018 | Los Angeles, CA Leveraging […]

Supply Chain Shifts in the Ever-Tumultuous Health Industry

Blog Posts

Fuld & Company

Capitalism has its flaws. Economists as diverse as Adam Smith to Karl Marx would agree to this premise. Yet one […]

The Rideshare Opportunity in Kenya and Across Sub-Saharan Africa

Blog Posts

Nairobi, Kenya, the hub of East Africa, is a bustling city marked by contradictions – for example, it houses a […]

What are the Competitive Strategy Implications of Uber’s European Regulatory Woes?

Blog Posts

Let me be clear right from the start – I loathe Uber. While I’m a big fan of ride-hailing services, […]

Managing Regulatory and Political Risk

Blog Posts

Fuld & Company

In our paper The Global Economy’s New Frontiers, my colleague Nathaniel Emmons and I argue that when investing in emerging economies, […]

Wearable Devices Provide a New Look for the Modern Clinical Trial

Blog Posts

Fuld & Company

Clinical development has historically been a laborious and expensive process, driven by lengthy patient recruitment timelines, increasingly complex study designs, […]

Don’t Underestimate WeWork

Blog Posts

I have a nice office at Fuld & Company, it’s one of the perks of being the CEO. In my […]